Walgreen's (WAG) Q110 Earnings Preview: Potential Boost from H1N1 Vaccines? StreetInsider.com - 2 hours ago Walgreen Co. (NYSE: WAG) is trading lower today before the company reports their first quarter earnings before the market opens on Monday, December 21, 2009. Shares are down 2.46% to $37.30 … Walgreen (NYSE: WAG): First Quarter Earnings Preview 2010 - istockAnalyst.com
Tags: analysis,
clinical,
deutsche-bank,
florida,
image,
medical,
more-news-related-to-wag,
potential,
potential-boost,
price,
related,
Review,
vaccines Sector Benefits From Impending Health Care Legislation Forecast By Lazard Capital Expert The Wall Street Transcript - 29 minutes ago December 9, 2009 - The Wall Street Transcript has just published Consumer Health Services Report offering a timely review of the Health Services sector. This Special Report contains expert …
Prevalence of metabolic syndrome in adults, as well as the increasing prevalence of pediatric obesity, has spurred research into how the condition may affect children and adolescents. Pharmacists should be able to define insulin resistance and metabolic syndrome in children and adults according to national guidelines, list the risk factors associated with metabolic syndrome in children that may increase their risk as adults, describe the role of lifestyle modification in children and adults with metabolic syndrome, and identify the role of medical and surgical treatment for metabolic syndrome and/or obesity.
HealthTrans, a healthcare management solutions company, recently announced changes it made to ensure market readiness for changes to Average Wholesale Prices (AWP). HealthTrans successfully transitioned clients Sept. 16,according to a statement to Drug Topics, and is now effectively processing claims based on Wholesale Acquisition Cost (WAC).
GlaxoSmithKline has announced the FDA Vaccines and Related Biological Products Advisory Committee voted that clinical data support both the efficacy and safety of CERVARIX, the company?s candidate cervical cancer vaccine.
